Concepedia

Angelika Banzhoff

AB

Statistics

Publications

37

Citations

2.1K

H-Index

24

Active since

1984

Affiliations

Novartis (Germany)(Current)

Novartis (Italy)

University of Siena

Justus-Liebig-Universität Gießen

University of Regensburg

Angelika Banzhoff is an author at Novartis (Germany) specializing in infectious diseases, vaccination, and immunology.

ORCID

Publications per year

1984–2024

37

Publications

37

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

Grazia Galli, Kathy Hancock, Katja Höschler et al. · Proceedings of the National Academy of Sciences · 2009 · 261 citations · Full text

, , +17

Adjuvanted H5N1 vaccine induces early CD4 <sup>+</sup> T cell response that predicts long-term persistence of protective antibody levels

Grazia Galli, Duccio Medini, Erica Borgogni et al. · Proceedings of the National Academy of Sciences · 2009 · 258 citations · Full text

, , +17

MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults

Angelika Banzhoff, Roberto Gasparini, Franco Laghi‐Pasini et al. · PLoS ONE · 2009 · 192 citations · Full text

, , +17

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.

Deborah J. Briggs, Angelika Banzhoff, Uwe Nicolay et al. · PubMed · 2000 · 148 citations

, , +14

Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals

Beatriz P. Quiambao, Efren M. Dimaano, Cristina Ambas et al. · Vaccine · 2004 · 97 citations

, , +17

1–5 of 37